Terms ending in 2028
Every in-force patent on Eisai Co., Ltd.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,741,450 | Antigenic Gm-Csf Peptides and Antibodies to Gm-Csf In force · High confidence | Eisai, Inc. | In force | High confidence | |
| US 8,618,075 | Certain Compounds, Compositions and Methods In force · High confidence | Taiho Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 8,951,987 | Certain Compounds, Compositions and Methods In force · High confidence | Taiho Pharmaceutical Co., Ltd. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Eisai Co., Ltd..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.